Impact of Sending an Sms on the Rate of Telephone Responses of Subjects Contacted 3 Months After the Suicidal Act (EVAREST3)

February 7, 2024 updated by: Centre Psychothérapique de Nancy

Impact of Sending an Sms in the "Vigilans Lorraine" Monitoring System on the Rate of Telephone Responses of Subjects Contacted 3 Months After a Passage to the Suicidal Act

The objective of this controlled, randomized, monocentric study is to compare the response rate of the call at 3 months of the groups with or without short message service (SMS) 48 hours before, for the subjects having benefited from the device "VigilanS Lorraine". The secondary objectives will be to appreciate the satisfaction of the subjects towards the sending of the SMS as well as to compare the delay of suicidal recidivism according to whether the subjects answered or not to the call of evaluation at 3 months of the passage to the act The main question it aims to answer is: What impact, on the rate of successful calls, could sending a text message 48 hours before the 3-month evaluation phone call have on subjects benefiting from the VigilanS device?

The participants will be divided into 2 groups:

  • 1st group: SMS sent 48 hours before the 3-month evaluation call planned in the framework of the "VigilanS Lorraine" program.
  • 2nd group (control): evaluation call at 3 months planned within the framework of the "VigilanS Lorraine" system, not preceded by an SMS 48 hours before.

The desired effect was an increase in the percentage of successful calls at 3 months, allowing for possible evaluations at 3 months in order to identify, evaluate and accompany subjects still in a suicidal crisis and thus avoid a recurrence of the act and thus a suicide.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

250

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Naoual MELLOUKI BENDIM'RED, PhD
  • Phone Number: 0033 0383925267
  • Email: unic@cpn-laxou.com

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Having made a suicide attempt (first-time suicide or not)
  • Hosted at the Central Hospital of Nancy
  • Included in the "VigilanS Lorraine" monitoring system
  • Not presenting criteria for non-inclusion in the "VigilanS Lorraine" system, namely:

    • Guardianship
    • Held
    • Dementia
    • Not speaking French
  • Subject having received information relating to the progress of the EVAREST 3 study and having given their consent to participate
  • Subject affiliated or entitled to a social security scheme

Exclusion Criteria:

  • Subject without mobile phone
  • Participation in another interventional study on the prevention of suicidal recidivism
  • Subject under curatorship who was not assisted by his curator to give his consent to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: SMS
Sending an SMS 48 hours before the 3-month evaluation call planned as part of the VigilanS Lorraine system

Each subject of the experimental group will receive, in addition to the usual procedure of the VigilanS Lorraine device, an SMS 48 hours before the telephone call for evaluation at 3 months, warning him of this call.

The time of this SMS has been set at 1:00 p.m. for all the people included in this group.

At the end of this evaluation call, the caller will pass a satisfaction questionnaire to the subject in relation to the sending of the SMS

No Intervention: Without SMS
without Sending an SMS 48 hours before the 3-month evaluation call planned as part of the VigilanS Lorraine system

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of successful calls during the 3 month evaluation
Time Frame: 3 months
. A call is considered unsuccessful after 3 call attempts at 3 different times over 3 consecutive working days.
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Satisfaction survey
Time Frame: 3 months
subjective experience of the subject having benefited from the sending of the SMS in relation to the intervention, the delay between the sending of the SMS and the telephone call
3 months
SMS delivery status:
Time Frame: 3 months
issued/not issued
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Xavier SIPP, Mr., Centre Psychothérapique de Nancy

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2024

Primary Completion (Estimated)

June 1, 2024

Study Completion (Estimated)

June 1, 2025

Study Registration Dates

First Submitted

July 21, 2023

First Submitted That Met QC Criteria

July 21, 2023

First Posted (Actual)

July 28, 2023

Study Record Updates

Last Update Posted (Actual)

February 8, 2024

Last Update Submitted That Met QC Criteria

February 7, 2024

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2022-A01404-39
  • RIPH-2022-02 (Other Identifier: Centre Psychothérapique de Nancy)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Suicide, Attempted

Clinical Trials on IMPACT OF SENDING AN SMS

Subscribe